1 We have shown earlier that activation of metabotropic glutamate (mGlu) receptors using a group I-speci®c mGlu receptor agonist, (RS)-3,5-dihydroxyphenylglycine (DHPG), can induce long-term depression (LTD) in the CA1 region of the hippocampus. In an attempt to determine the signal transduction mechanisms involved in this form of synaptic plasticity, we have tested the eects of a range of inhibitors on DHPG-induced LTD. 2 In vitro grease-gap electrophysiological recordings were performed in the rat hippocampal CA1 region. 3 We have found that DHPG-induced LTD is resistant to the two potent protein kinase C (PKC) inhibitors, GoÈ 6976 (10 mM) and GoÈ 6983 (10 mM), the potent and selective protein kinase A (PKA) inhibitor, KT 5720 (10 mM), and the potent broad spectrum kinase inhibitor, staurosporine (10 mM). 4 In contrast, non-selective inhibitors of protein phosphatases (PP1 and PP2A), okadaic acid (1 mM) or calyculin A (1 mM), facilitated DHPG-induced LTD. However, an inhibitor of protein phosphatase 2B, FK 506 (1 mM), did not in¯uence this process. 5 The PP1/PP2A protein phosphatase inhibitors, but none of the other agents tested, also inhibited (S)-a-methyl-4-carboxyphenylglycine (MCPG)-induced reversal of DHPG-induced LTD. 6 These data suggest that activation of neither PKC nor PKA is involved in DHPG-induced LTD. They do, however, suggest that the process is under regulation by protein phosphorylation and dephosphorylation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.